A retrospective study to evaluate the short and long-term adverse events associated with outpatient percutaneous endoscopy gastro-jejunal tube (PEG-J) tube insertion for Levodopa/carbidopa intestinal gel (LCIG) administration in patients with Parkinson's disease
Latest Information Update: 10 Jul 2020
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- 10 Jul 2020 New trial record
- 19 May 2020 Results published in Gasteroenterology in conjunction with Digestive Disease Week 2020.